跳至主要内容
临床试验/NCT01028443
NCT01028443已完成4 期

Efficacy of Topical Cyclosporine A for Treatment and Prevention of Graft Rejection in Corneal Grafts With Previous Rejection Episodes

Shahid Beheshti University of Medical Sciences1 个研究点 分布在 1 个国家开始时间: 2009年12月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
试验地点
1
主要终点
The rate of rejection after drop sessation

研究概览

简要总结

The use of topical Cyclosporine A early after an episode of endothelial graft rejection after penetrating keratoplasty and continuing its administration for 6 months can reduce the course of that episode and recurrence of the rejection.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Penetrating keratoplasty in eyes without vascularization

排除标准

  • History of previous intraocular surgery

研究组 & 干预措施

Cyclosporine A 2%

Active Comparator

干预措施: Sandimmune (Drug)

Artificial tears

Placebo Comparator

干预措施: Artelose (Drug)

结局指标

主要结局

The rate of rejection after drop sessation

时间窗: 3 years

次要结局

未报告次要终点

研究者

研究点 (1)

Loading locations...

相似试验